Blog Posts in 2012
113 results found. Viewing page 1 of 5.
Go to page
Posted on May 16, 2012 By Pharmaceutical Injury Attorney
David Brennan, CEO of AstraZeneca, is leaving his position following a dramatic drop in the company's performance. Investors have recently become discontent with the performance of the company. ...
Continue reading "AstraZeneca CEO Steps Down as Earnings Fall" »
Posted on May 14, 2012 By Pharmaceutical Injury Lawyer
Ongoing studies have been taking place to determine just how dangerous the drug Pradaxa is. Pradaxa is a drug that is prescribed to patients to treat blood clots and prevent strokes. Patients started ...
Continue reading "New Research Says Pradaxa More Dangerous Than Warfarin" »
Posted on May 11, 2012 By Medical Injury Attorney
Abbott Laboratories has agreed to pay $1.6 billion in fines to state and federal governments for illegally promoting unapproved uses of its anti-seizure drug Depakote. At specific issue was the ...
Continue reading "Depakote Makers Pay $1.6 Billion over Illegal Drug Marketing Practices" »
Posted on May 11, 2012 By Personal Injury Attorney
Five pharmaceutical companies—Actavis, Boehringer Ingelheim, Dey, GlaxoSmithKline and Schering-Plough—will pay the state of Louisiana a combined $25.2 million for misreporting drug price ...
Continue reading "Louisiana Attorney General gets $25.2 Million from Fraudulent Drug Companies" »
Posted on May 11, 2012 By Pharmaceutical Injury Lawyer
According to recent reports, the U.S. District Court for the West Virginia transvaginal mesh MDL is underway and running smoothly. This case was consolidated in February of this year and includes four ...
Continue reading "West Virginia Trans-Vaginal MDL Running Smoothly" »
Posted on May 10, 2012 By Medical Injury Attorney
Existing policies by the Food and Drug Administration (FDA) allow "accelerated approval" of some developing drugs. "Accelerated approval" lets the FDA approve drugs in phase II of ...
Continue reading "Debate over FDA "Conditional Approval" of New Drugs" »
Posted on May 10, 2012 By Personal Injury Attorney
Five years ago, the Food and Drug Administration (FDA) received permission from Congress to set up a unique identifier system to monitor medical devices after they were approved for entry into the ...
Continue reading "FDA has no Monitoring System for Medical Devices" »
Posted on May 9, 2012 By Personal Injury Attorney
Thousands of individuals suffer from post-traumatic-stress disorder (PTSD), a condition characterized by a wide variety of intense symptoms experienced in the wake of a traumatic event. As incidents ...
Continue reading "Psychiatrists Want a New Name for PTSD" »
Posted on May 9, 2012 By Personal Injury Attorney
The American Association of Retired Persons (AARP) has joined a class-action California nursing home neglect suit which claims the Ventura Convalescent Hospital has broken the law by providing ...
Continue reading "AARP Sues Nursing Home over Antipsychotic Drug Prescriptions" »
Posted on May 9, 2012 By Pharmaceutical Injury Lawyer
Federal judge Rebecca Doherty who is overseeing the Actos drug injury multidistrict litigation (MDL) has recently made a decision that will make it easier for patients injured by the drug to join the ...
Continue reading "Joining an Actos MDL May Be Easier Than You Think" »
Posted on May 8, 2012 By Medical Injury Attorney
A new Food and Drug Administration (FDA) study published this week in the New England Journal of Medicine warns that women who take bone-building drugs to treat osteoporosis are at risk of developing ...
Continue reading "Long Term use of Osteoporosis Drugs may be Harmful" »
Posted on May 8, 2012 By Personal Injury Attorney
Cellulaze is a new laser treatment for cellulite removal. It was approved by the Food and Drug Administration (FDA) for the improvement of cellulite for up to three months. While doctors and some ...
Continue reading "What Doctors aren't Telling you about Cellulaze" »
Posted on May 8, 2012 By Drug Injury Lawyer
A new report published by the Institute of Medicine (IOM) says that the Food and Drug Administration (FDA) needs to create a public database to track a drug's safety record even after it receives ...
Continue reading "Report Reveals Current FDA Drug Safety Tracking System Needs Improvement" »
Posted on May 7, 2012 By drug Injury Attorney
Two senators have opened an investigation into financial ties between the producers of prescription painkillers and pain experts in the medical field. The Senate Finance Committee published several ...
Continue reading "Pain Experts in Unethical Relationship with Makers of Painkillers" »
Posted on May 7, 2012 By Medical Injury Attorney
A new study published by researchers at the Food and Drug Administration (FDA) reveals that at least half of the drug labels they reviewed did not contain any information related to the safety of the ...
Continue reading "Too Many Medications Don't Provide Children's Dosing Information" »
Posted on May 6, 2012 By Drug Defect Lawyer
ACE (angiotensin converting enzyme) inhibitors, a class of drug used to lower blood pressure, work by blocking the formation of angiotensin II, a potent chemical that narrows blood vessels, raising ...
Continue reading "New Concern Over Severe Side Effect of Blood Pressure Drug" »
Posted on May 5, 2012 By Medical Injury Lawyer
The first of approximately 600 federal cases related to C.R. Bard Inc's dangerous vaginal mesh implant is set for February 5, 2013. More than 75,000 women have vaginal mesh devices inserted each ...
Continue reading "Trial Date Set for First Federal Vaginal Mesh Trial" »
Posted on May 3, 2012 By Pharmaceutical Injury Lawyer
After any assessed risk with a product, the FDA will then intervene in some way. This may take on a number of different forms. One thing they will do is regulate product labeling. Products such as ...
Continue reading "How the FDA Intervenes" »
Posted on May 3, 2012 By Drug Injuries Lawyer
Public Citizen, a consumer safety advocate group, petitioned the Food and Drug Administration (FDA) last week to recall the diabetes drug Victoza because of the dangerous side effects it can cause in ...
Continue reading "Consumer Group Urges Recall of Dangerous Drug" »
Posted on May 2, 2012 By Pharmaceutical Injury Attorney
The Food and Drug Administration has a process by which they assess and manage the possible risk of products. This goes for products that are both on the market and those that have not yet entered the ...
Continue reading "How the FDA Assesses Risk" »
Posted on May 1, 2012 By Drug Injury Lawyer
The Prescription Drug User Fee Act (PDUFA) of 1992 ruled that companies applying for approval of new drugs or medical devices would be required to pay a user fee to the Food and Drug Administration ...
Continue reading "Exploring the Debate Over FDA User Fees" »
Posted on Apr 30, 2012 By Dangerous Drug Lawyer
A New Haven jury has ruled that drug maker Pfizer must pay a woman at least $4 million in damages because she developed breast cancer after taking Prempro, the company's menopause drug. The jury ...
Continue reading "Pfizer Must Pay Damages for Dangerous Drug" »
Posted on Apr 27, 2012 By Pharmaceutical Injury Lawyer
Boston Scientific Corporation's Cognis and Teligen defibrillators may be at risk for malfunction. These defibrillators are used to restart a stopped heart. The device has been linked to one known ...
Continue reading "Boston Scientific Defibrillator May Malfunction" »
Posted on Apr 26, 2012 By Pharmaceutical Injury Attorney
A $64 million class-action settlement has officially received the OK which means that parents of children who took the antidepressant can start receiving reimbursements. The suit was based upon the ...
Continue reading "Paxil Settlement Reaches $64 Million" »
Posted on Apr 21, 2012 By Pharmaceutical Injury Attorney
St. Jude Medical Inc. has decided to stop selling two different types of heart device wires after they were discovered to come out of insulation and cause problems for patients. The wires were ...
Continue reading "St. Jude Medical to Stop Sales of Faulty Heart Device Wires" »
113 results found. Viewing page 1 of 5.
Go to page